BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11919651)

  • 1. Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin.
    Sato S; Yamate J; Saito T; Hosokawa T; Saito S; Kurasaki M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):277-83. PubMed ID: 11919651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of dietary azuki bean (Vigna angularis) seed coats against renal interstitial fibrosis of rats induced by cisplatin.
    Sato S; Hori Y; Yamate J; Saito T; Kurasaki M; Hatai A
    Nutrition; 2005 Apr; 21(4):504-11. PubMed ID: 15811772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of rat renal interstitial fibrosis induced by repeated injection of cisplatin, with special reference to the kinetics of macrophages and myofibroblasts.
    Yamate J; Ishida A; Tsujino K; Tatsumi M; Nakatsuji S; Kuwamura M; Kotani T; Sakuma S
    Toxicol Pathol; 1996; 24(2):199-206. PubMed ID: 8992610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced renal interstitial fibrosis in neonatal rats, developing as solitary nephron unit lesions.
    Yamate J; Machida Y; Ide M; Kuwamura M; Kotani T; Sawamoto O; LaMarre J
    Toxicol Pathol; 2005; 33(2):207-17. PubMed ID: 15902963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lipopolysaccharide on the appearance of macrophage populations and fibrogenesis in cisplatin-induced rat renal injury.
    Yamate J; Machida Y; Ide M; Kuwamura M; Sawamoto O; LaMarre J
    Exp Toxicol Pathol; 2004 Oct; 56(1-2):13-24. PubMed ID: 15581271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
    Saad SY; Al-Rikabi AC
    Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies.
    Yang T; Vesey DA; Johnson DW; Wei MQ; Gobe GC
    Transl Res; 2007 Jul; 150(1):40-50. PubMed ID: 17585862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of cisplatin-induced rat renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.
    Yamamato E; Izawa T; Sawamoto O; Juniantito V; Kuwamura M; Yamate J
    Exp Toxicol Pathol; 2012 Sep; 64(6):625-31. PubMed ID: 21256724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
    Saad SY; Najjar TA; Alashari M
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
    Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
    Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
    González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
    Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats.
    Yamate J; Sato K; Ide M; Nakanishi M; Kuwamura M; Sakuma S; Nakatsuji S
    Vet Pathol; 2002 May; 39(3):322-33. PubMed ID: 12014496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parthenolide reduces cisplatin-induced renal damage.
    Francescato HD; Costa RS; Scavone C; Coimbra TM
    Toxicology; 2007 Jan; 230(1):64-75. PubMed ID: 17156909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure.
    Zhou H; Kato A; Yasuda H; Miyaji T; Fujigaki Y; Yamamoto T; Yonemura K; Hishida A
    Toxicol Appl Pharmacol; 2004 Oct; 200(2):111-20. PubMed ID: 15476864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis.
    Kramer AB; Ricardo SD; Kelly DJ; Waanders F; van Goor H; Navis G
    J Pathol; 2005 Dec; 207(4):483-92. PubMed ID: 16211543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathological study regarding the protective effect of elastase on cis-platinum-induced renal toxicity].
    Suzuki M; Ohwada M; Sekiguchi I; Tamada T
    Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):941-7. PubMed ID: 2778382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.